{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/novel-remote-visit-approach-japan-advancing-patient-centric-als-clinical-trials#webpage",
"url": "https://www.fortrea.com/insights/novel-remote-visit-approach-japan-advancing-patient-centric-als-clinical-trials",
"name": "Novel Remote Visit Approach in Japan: Advancing Patient-Centric ALS Clinical Trials",
"description": "This Fortrea case study explores how patient-centric ALS clinical trials were designed to reduce patient burden and support continued participation during a global Phase II study. The study involved patients with amyotrophic lateral sclerosis (ALS), where disease progression and mobility limitations created challenges for traditional site-based participation. The case study highlights how remote participation strategies, in-home clinical trial visits, and decentralized operational support were implemented to improve accessibility and reduce the physical burden associated with frequent travel to clinical sites. Fortrea coordinated patient support activities, remote visit planning, and collaboration with investigator sites and healthcare providers to maintain continuity throughout the study lifecycle. By integrating patient-centric clinical trial management with decentralized support approaches, the strategy enabled improved participation continuity and reduced burden across ALS clinical trial operations."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Novel Remote Visit Approach in Japan: Advancing Patient-Centric ALS Clinical Trials",
"item": "https://www.fortrea.com/insights/novel-remote-visit-approach-japan-advancing-patient-centric-als-clinical-trials"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/novel-remote-visit-approach-japan-advancing-patient-centric-als-clinical-trials#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/novel-remote-visit-approach-japan-advancing-patient-centric-als-clinical-trials#webpage"
},
"headline": "Novel Remote Visit Approach in Japan: Advancing Patient-Centric ALS Clinical Trials",
"description": "This Fortrea case study explores how patient-centric ALS clinical trials were designed to reduce patient burden and support continued participation during a global Phase II study. The study involved patients with amyotrophic lateral sclerosis (ALS), where disease progression and mobility limitations created challenges for traditional site-based participation. The case study highlights how remote participation strategies, in-home clinical trial visits, and decentralized operational support were implemented to improve accessibility and reduce the physical burden associated with frequent travel to clinical sites. Fortrea coordinated patient support activities, remote visit planning, and collaboration with investigator sites and healthcare providers to maintain continuity throughout the study lifecycle. By integrating patient-centric clinical trial management with decentralized support approaches, the strategy enabled improved participation continuity and reduced burden across ALS clinical trial operations.",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-09-04",
"dateModified": "2025-09-04",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-09/case-study-als-patient-centric-trials-japan.pdf",
"encodingFormat": "application/pdf"
}
}
]
}